Despite APOE ε4 being overrepresented in the AD cohort, we observe a consistent molecular signature associated with APOE ε4 across multiple neurodegenerative diseases, highlighting an underrecognized role for this variant beyond AD that may have been overlooked due to its historically strong link with AD risk. This evidence concerns the gene APOE and neurodegenerative disease.